Where next for Acacia Pharma on positive PhIII PONV data?

Private UK company Acacia Pharma is hoping to return dopamine antagonists to the arsenal of drugs available for post-operative nausea and vomiting (PONV) following positive top-line results from two Phase III studies of its lead product APD421.